![NHS](https://eurohealthleaders.com/wp-content/uploads/2024/09/NHS-Approves-First-Ever-Drug-for-Von-Hippel-Lindau-Disease-Offering-New-Hope-for-Patients.jpg)
NHS Approves First-Ever Drug for Von Hippel-Lindau Disease, Offering New Hope for Patients
NHS patients in England with von Hippel-Lindau (VHL) disease now have access to the first-ever drug specifically approved for their
NHS patients in England with von Hippel-Lindau (VHL) disease now have access to the first-ever drug specifically approved for their
A surge in preventive healthcare in Czechia marks a positive shift in public health behavior, as citizens increasingly focus on
In a groundbreaking public health initiative, the NHS has officially launched its first-ever vaccination program against respiratory syncytial virus (RSV)
The World Health Organization (WHO) has called on manufacturers of mpox in vitro diagnostics (IVDs) to submit expressions of interest
Concussion patients often face persistent and severe symptoms following a head injury, yet traditional diagnostic methods frequently fall short in
A team of scientists and researchers is embarking on a groundbreaking project to analyze hundreds of thousands of brain scans
Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University have successfully induced a hibernation-like state in tadpoles
The World Health Organization (WHO) has declared the surge of mpox in the Democratic Republic of the Congo (DRC) and
Obesity treatment should prioritize health improvement over mere weight loss, according to international obesity experts in a new paper published
An emerging virus dubbed ‘sloth fever’ has sparked concerns after 19 cases were confirmed in Europe, marking the first known
Euro Health Leaders stands out as the premier destination for anyone seeking a comprehensive and insightful view of the dynamic healthcare landscape in Europe.